¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

KSC 2019 (´ëÇѽÉÀåÇÐȸ Á¦63Â÷ Ãß°èÇмú´ëȸ) : 2019-10-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
KSC 2019 (´ëÇѽÉÀåÇÐȸ Á¦63Â÷ Ãß°èÇмú´ëȸ) : 2019-10-20
±³À°ÀÏÀÚ : 2019-10-20
±³À°Àå¼Ò : ¿öÄ¿Èú È£ÅÚ Art Ȧ ¿Ü  
±³À°ÁÖÁ¦ : KSC 2019 (´ëÇѽÉÀåÇÐȸ Á¦63Â÷ Ãß°èÇмú´ëȸ)
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258  
À̸ÞÀÏ : herz8@circulation.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡   (ÀÏ¹Ý 5Á¡ / Çʼö 1Á¡)  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ-100000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-70000ÇöÀåµî·Ï: ±³¼ö ¹× °³¿øÀÇ-120000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-90000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-20 Art 08:40~08:55 Pulmonary Hypertension with Significant Left to Right Shunt: How to Treat  ¹éÀç¼÷(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 10-20 Art 08:55~09:10 Treatment of Eisenmenger Syndrome in Adult  Àå¼ÒÀÍ(¼¼Á¾º´¿ø) 
±³À°½Ã°£ 10-20 Art 09:10~09:25 Pulmonary Thromboembolism in ACHD  ¹ÚÁ¤¶û(°æ»óÀÇ´ë) 
±³À°½Ã°£ 10-20 Art 09:25~09:40 Combined Pre- and Post-capillary Pulmonary Hypertension in ACHD  ±èÇü°ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-20 Art 09:40~09:55 Differential Diagnosis of Pulmonary Hypertension in ADHD: Multiple Comorbidity Condition  À强¾Æ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 10-20 Art 09:55~10:10 Discussion  () 
È޽Ġ10-20  10:10~10:20 Break  () 
±³À°½Ã°£ 10-20 Theatre 10:20~10:40 The Past, Present and Future of HF Medical Treatment  Barry Greenberg(Univ. of California San Diego USA) 
±³À°½Ã°£ 10-20 Theatre 10:40~11:00 The Past, Present and Future of CRT  Eugene S. Chung(The Christ Hospital Cincinnati OH USA) 
±³À°½Ã°£ 10-20 Theatre 11:00~11:20 The Past, Present and Future of Heart Transplantation  Jon A. Kobashigawa(Cedars-Sinai USA) 
Åä·Ð 10-20 Theatre 11:20~11:50 Discussion  () 
È޽Ġ10-20  11:50~12:00 Break  () 
±³À°½Ã°£ 10-20 Cosmos 12:00~12:20 Combination Therapy of Antihypertensive Drugs for CV Protection Amosartan Family  ¼ÕÀϼ®(°æÈñÀÇ´ë) 
±³À°½Ã°£ 10-20 Cosmos 12:20~12:40 The Benefits of Intensive Lipid Lowering  ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 10-20 Abstract/Case zone & Moderated Poster zone 12:40~14:00 Case Presentation & Moderated Poster  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 10-20 Theatre 14:00~14:25 ÃֽŠ»ç·Ê¸¦ ÅëÇØ º» ÀÇ·á±â°ü-Á¦¾àȸ»ç/±â±âȸ»ç À±¸® Áöħ - ûŹ±ÝÁö¹ý ½ÃÇà ÀÌÈÄ  Á¶°Ç¹Ì(¼­¿ï¾Æ»êº´¿ø ¹ý¹«ÆÀ) 
Åä·Ð 10-20 Theatre 14:25~14:30 Discussion  () 
±³À°½Ã°£ 10-20 Theatre 14:30~14:55 º¯È­ÇÏ´Â ¿¬±¸ÃâÆÇÀ±¸®  Çѵ¿¼ö(ÇѾçÀÇ´ë ÀÇÇÐÇмúÁöÆíÁýÀÎÇùÀÇȸ ÃâÆÇÀ±¸®À§¿øÀå) 
Åä·Ð 10-20 Theatre 14:55~15:00 Discussion  () 
±³À°½Ã°£ 10-20 Theatre 15:00~15:25 ÀÇ»çÀ±¸®ÁöħÀÇ ¹ýÀûÇؼ®  ¹ÚÇü¿í(´Ü±¹ÀÇ´ë) 
Åä·Ð 10-20 Theatre 15:25~15:30 Discussion  () 
È޽Ġ10-20  15:30~15:40 Break  () 
±³À°½Ã°£ 10-20 Walker 2 15:40~16:00 How to Select Optimal NOAC in AF Patients Undergoing PCI? - Rivaroxaban vs. Dabigatran vs. Apixaban  ¹èÀåȯ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 10-20 Walker 2 16:00~16:20 How to Manage Blood Thinners during Procedure or Surgery? - Antiplatelet or Anticoagulant for Primary and Secondary Prevention  ¾È¼º±Õ(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 10-20 Walker 2 16:20~16:40 How to Choose Optimal Blood Thinner after Structural Cardiovascular Intervention?  ¹Ú´ö¿ì(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 10-20 Walker 2 16:40~17:00 How to Adjust Blood Thinners in Patients with Old Age or CKD? - Dose or Regimen Adjustment According to CrCl vs. GFR  ±è¿ø(°æÈñÀÇ´ë) 
Åä·Ð 10-20 Walker 2 17:00~17:10 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" KSC 2019 (´ëÇѽÉÀåÇÐȸ Á¦63Â÷ Ãß°èÇмú´ëȸ) : 2019-10-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦5Â÷ ÇÏÁöÁ¤¸Æ·ù¿¬±¸È¸ Çмú½ÉÆ÷Áö¿ò : 2019-10-20
´ÙÀ½±Û ¼­¿ï°­³²¼º¸ðº´¿ø Á¦46ȸ 2019³â ´ëÇÑÀϹݰúÀÇ»çȸ Ãß°è ¿¬¼ö°­Á : 2019-10-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20574 °­¿ø ´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ - 2024³â Ãá°è½ÉÆ÷Áö¾ö (2ÀÏÂ÷) : 2024-06-08 0 34 2024-04-29
20573 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2024 Kyung Hee Knee Symposium : 2024-06-08 0 46 2024-04-29
20572 ¼­¿ï 2024³â ´ëÇѽÉÇ÷°ü¾à¹°Ä¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08 0 46 2024-04-29
20571 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ °¨¿°°ü¸®ÀÇ»ç ¿¬¼ö±³À° : 2024-06-08 0 49 2024-04-29
20570 Á¦ÁÖ 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ Á¦ÁÖÁöȸ ¿¬¼ö°­Á : 2024-06-08 0 46 2024-04-29
20569 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ ¼Ò¾Æû¼Ò³â ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ 1Â÷ ½ÉÆ÷Áö¾ö : 2024-06-08 0 43 2024-04-29
20568 °­¿ø ´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ - 2024³â Ãá°è½ÉÆ÷Áö¾ö (1ÀÏÂ÷) : 2024-06-07 0 48 2024-04-29
20567 ´ëÀü Á¦114Â÷ ´ëÇѽŰæ¿Ü°úÇÐȸ ´ëÀüÃæûÁöȸ Á¤±âÇмú´ëȸ : 2024-06-07 0 38 2024-04-29
20566 ´ë±¸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2024-06-04 0 41 2024-04-29
20565 ¼­¿ï Á¦24ȸ ´ëÇÑ°»³â±âÇÐȸ 2024 Ãá°èÇмú´ëȸ : 2024-06-02 0 27 2024-04-29
20564 ¼­¿ï 2024 ´ëÇÑÄ¡¸ÅÇÐȸ Ä¡¸ÅƯº°µî±Þ ÀÇ»ç¼Ò°ß¼­ ÀÛ¼º ±³À° : 2024-06-02 0 44 2024-04-29
20563 ¼­¿ï ÀÌ´ë¼­¿ïº´¿ø °³¿ø 5Áֳ⠱â³ä ¿Ü°ú ½ÉÆ÷Áö¾ö ¹× °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-02 0 52 2024-04-29
20562 ¼­¿ï Á¦ 14Â÷ ´ëÇѸð¹ßÀ̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-02 0 38 2024-04-29
20561 ¼­¿ï ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ IFFAS 2024 (3ÀÏÂ÷) : 2024-06-01 0 55 2024-04-29
20560 °æ±â 2024 ¼º³²½ÃÀÇ»çȸ »ó¹Ý±â Çмú´ëȸ : 2024-06-01 0 44 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷